Greer Massey, PhD, is Chief Scientific Officer at Molecular Designs and guides the development of multiplex PCR assays for research use, as well as complementary reagents and instrumentation. Previously, Dr. Massey led Research & Development at Assurance Scientific, where she directed efforts for their SARS-CoV-2 emergency use authorization for symptomatic and asymptomatic testing. She also helped establish the consulting services. Before that, Dr. Massey managed the Bioanalytical Department at Southern Research and developed multiplex assays and their lyophilization as Senior Products Manager at BioGX, Inc. Dr. Massey received both her MS in Biology and PhD in Microbiology from the University of Alabama at Birmingham.
Antibiotic resistance is a growing global threat with serious health and economic consequences. Yet there is progress – from rapid PCR diagnostics and AI-driven research to new drug development and innovative funding models.